Levine Appointed to the Helen McWhorter Chair in Small Animal Medicine

COLLEGE STATION, Texas – Dr. Jonathan Levine, associate professor in neurology at the Texas A&M College of Veterinary Medicine & Biomedical Sciences (CVM), has recently been appointed to the Helen McWhorter Chair in Small Animal Medicine.

Dr. Jonathan Levine
Dr. Jonathan Levine

A chair is established to support and enhance the professional activities of an accomplished faculty member. The chair is usually created by a donation that is placed into an endowment, where the funds are invested and earnings from the investment are used to support the faculty member’s work. The principal amount from the donation is not spent, and will remain in place to provide support.“Dr. Levine is an established leader not only on our veterinary neurology service, but also within the neurology discipline,” said Dr. Eleanor M. Green, the Carl B. King Dean of Veterinary Medicine. “His translational research approach is building impactful collaborations with his counterparts in human medicine in an effort to improve the health of both animals and people. He is truly deserving of this recognition. Recognizing outstanding faculty through a chair appointment such as the Helen McWhorter Chair in Small Animal Medicine is tremendously beneficial to the college and we are grateful for the support received from this endowed chair.”

“The support from endowed chairs allows us to recruit and retain the finest faculty members,” said Dr. Guy Sheppard, Director of Development at the CVM.

Ms. McWhorter, who was a generous benefactor to the CVM from Baytown, Texas, established this endowed chair and another generous scholarship endowment through a gift from her will. In addition to her support of the CVM, Ms. McWhorter also placed her dogs to be cared for at the Stevenson Companion Animal Life-Care Center when she was no longer able to do so.

“I am humbled and honored to receive the McWhorter Chair in Small Animal Medicine,” said Levine. “This will be a tremendous resource to further develop and support our programs in translational medicine.”


Print
Show Buttons
Hide Buttons